microRNA | Expression in CRC | Tissue | Reference | Function in ESC [16] |
---|---|---|---|---|
hsa-miR-17-3p | Up | Tumor tissue | [91] | Pluripotency |
Up | Serum | [92] | ||
Up | Tumor tissue | [93] | ||
Up | Tumor tissue | [34] | ||
hsa-miR-18a-5p | Up | Plasma | [94] | Pluripotency |
Up | Fixed tumor tissue | [95] | ||
Up | Tumor tissue | [93] | ||
Up | Tumor tissue | [34] | ||
Up | Tumor tissue | [96] | ||
hsa-miR-18b-5p | Up | Tumor tissue | [97] | Pluripotency |
Up | Tumor tissue | [98] | ||
hsa-miR-19a-3p | Up | Serum | [99] | Pluripotency |
Up | Serum | [92] | ||
Up | Tumor tissue | [98] | ||
Up | Tumor tissue | [96] | ||
hsa-miR-19b-3p | Up | Tumor tissue | [96] | Pluripotency |
Up | Serum | [92] | ||
hsa-miR-20a-5p | Up | Tumor tissue | [93] | Pluripotency |
Up | Serum | [92] | ||
Up | Fixed tumor tissue | [95] | ||
Up | Tumor tissue | [96] | ||
hsa-miR-20b-5p | Down | Tumor tissue | [100] | Pluripotency |
Up | Tumor tissue | [34] | ||
hsa-miR-21-5p | Up | Serum | [99] | Differentiation |
Up | Tumor tissue | [34] | ||
Up | Fixed tumor tissue | [95] | ||
Up | Tumor tissue | [96] | ||
Up | Tumor tissue | [101] | ||
hsa-miR-22-3p | Down | Tumor tissue | [102] | Differentiation |
Down | Tumor tissue | [103] | ||
Up | Tumor tissue | [101] | ||
hsa-miR-23a-3p | Up | Tumor tissue | [104] | Differentiation |
Up | Tumor tissue | [105] | ||
hsa-miR-24-3p | Up | Serum | [92] | Differentiation |
Down | Plasma | [36] | ||
hsa-miR-27a-3p | Up | Tumor tissue | [106] | Differentiation |
Down | Tumor tissue | [107] | ||
hsa-miR-29a-3p | Up | Tumor tissue | [96] | Differentiation |
Up | Fixed tumor tissue | [95] | ||
hsa-miR-29b | Down | Tumor tissue | [108] | Pluripotency |
Up | Tumor tissue | [96] | ||
hsa-miR-30a-5p | Down | Tumor tissue | [96] | Differentiation |
Down | Tumor tissue | [100] | ||
hsa-miR-92a-3p | Up | Tumor tissue | [93] | Pluripotency |
Up | Plasma | [93] | ||
Up | Tumor tissue | [34] | ||
Up | Fixed tumor tissue | [95] | ||
hsa-miR-101-3p | Down | Tumor tissue | [109] | Pluripotency |
Down | Serum | [110] | ||
Down | Tumor tissue | [111] | ||
hsa-miR-106a-5p | Up | Tumor tissue | [93] | Pluripotency |
Up | Tumor tissue | [34] | ||
Up | Tumor tissue | [96] | ||
hsa-miR-145-5p | Down | Tumor tissue | [112] | Differentiation |
Down | Tumor tissue | [34] | ||
Down | Tumor tissue | [96] | ||
hsa-miR-181d-5p | Up | Tumor tissue | [105] | Differentiation |
Up | Fixed tumor tissue | [113] | ||
hsa-miR-222-3p | Up | Tumor tissue | [93] | Differentiation |
Up | Plasma | [93] | ||
hsa-miR-302a-3p | Down | CRC cell lines | [114] | Pluripotency |
hsa-miR-302a-5p | Unknown | – | – | Pluripotency |
hsa-miR-302b-3p | Unknown | – | – | Pluripotency |
hsa-miR-302b-5p | Unknown | – | – | Pluripotency |
hsa-miR-302c-3p | Down | Plasma | [115] | Pluripotency |
hsa-miR-302d-3p | Unknown | – | – | Pluripotency |
hsa-miR-363-3p | Down | Tumor tissue | [116] | Pluripotency |
hsa-miR-371a-3p | Unknown | – | – | Pluripotency |
hsa-miR-372-3p | Up | Fixed tumor tissue | [113] | Pluripotency |
hsa-miR-373-3p | Up | Fixed tumor tissue | [113] | Pluripotency |
Up | Fixed tumor tissue | [117] |